Clinical trial
Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents
NCT00207948 · Children's National Research Institute, Other · Terminated
Key facts
| NCT number | NCT00207948 |
|---|---|
| Title | Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents |
| Official title | Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents |
| Lead sponsor | Children's National Research Institute, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Dose adjustment of Kaletra |
| Enrollment | 4 |
| Start date | Nov 1, 2004 |
| Primary completion | May 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Sep 21, 2005 |
| Last update posted | Aug 5, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: